Sanofi Pasteur MSD Limited

Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Patient Information Leaflet last updated on the eMC: 03/10/2011
PIL HBVAXPRO 5mcg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/07/2011 and displayed until 03/10/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 04/02/2010 and displayed until 05/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 01/12/2008 and displayed until 04/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 25/04/2007 and displayed until 01/12/2008
Reasons for adding or updating:
  • Change to manufacturer contact details
  • Change to side-effects
  • Change to Further Information section
Updated on 06/09/2006 and displayed until 25/04/2007
Reasons for adding or updating:
  • Introduction of new pack
Updated on 20/04/2006 and displayed until 06/09/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   hepatitis b vaccine (rDNA)